GDF3 propeptides and related methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S002600, C530S350000, C435S069100, C435S069700, C424S198100

Reexamination Certificate

active

07465706

ABSTRACT:
In certain aspects, the present invention provides compositions and methods for regulating body weight, in particular, for treating obesity and obesity-associate disorders. The present invention also provides methods of screening compounds that modulate activity of GDF3. The compositions and methods provided herein are also useful in treating diseases associated with abnormal activity of GDF3.

REFERENCES:
patent: 5637480 (1997-06-01), Celeste et al.
patent: 5808007 (1998-09-01), Lee et al.
patent: 5834179 (1998-11-01), Jones et al.
patent: 6004780 (1999-12-01), Soppet et al.
patent: 6071708 (2000-06-01), Jones et al.
patent: 6656708 (2003-12-01), Yu et al.
patent: 2003/0144176 (2003-07-01), Olson et al.
patent: 2003/0224501 (2003-12-01), Young et al.
patent: 2005/0244867 (2005-11-01), Soppet et al.
patent: WO-94/03600 (1994-02-01), None
patent: WO-94/15965 (1994-07-01), None
patent: WO-94/26893 (1994-11-01), None
patent: WO-95/24474 (1995-09-01), None
patent: WO-96/39431 (1996-12-01), None
patent: WO-99/37320 (1999-07-01), None
patent: WO02/43759 (2002-06-01), None
Krisch et al., EMBO J., 2000, 19(13):3314-3324.
Wang et al., “GDF-3 is an Adipogenic cytokine under high fat dietary condition,”Biochemical and Biophysical Research Communications, 321: 1024-1031 (2004).
Witthuhn et al., “Upregulation of Bone Morphogenetic Protein GDF-3/Vgr-2 Expression in Adipose Tissue of FABP4/aP2 Null Mice,”Cytokine, 14: 129-135 (2001).
Caricasole et al., “Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours,”Oncogene, 16: 95-103 (1998).
Clark et al., “Human Stellar, Nanog, and GDF3 Genes are Expressed in Pluripotent Cells and Map to Chromosome 12p13, a Hotspot for Teratocarcinoma,”Stem Cells, 22: 169-179 (2004).
McPherron et al., “GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines,”Journal of Biological Chemistry, 268 (5): 3444-9 (1993).
Chen, H., et al., “BMP10 is essential for maintaining cardiac growth during murine cardiogenesis,” Development, 131(9):2219-2231 (2004).
Constam et al., “Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases”, The Journal of Cell Biology, 144(1):139-149(1999).
Daluiski et al., “Bone Morphogenetic Protein-3 is a Negative Regulatory of Bone Density”, Nature Genetics, 27(1):84-88(2001).
Faucheux et al., “Opposing Actions of BMP3 and TGFbetal in Human Bone Marrow Stromal Cell Growth and Differentiation”, Biochemical and Biophysical Research Communications, 241(3):787-793(1997).
Hino et al., “Bone Morphogenetic Protein-3B (BMP-3B) Gene Expression is Correlated with Differentiation in Rat Calvarial Osteoblasts”, Biochemical and Biophysical Research Communications, 256(2):419-424(1999).
Hino et al., “Bone Morphogenetic Protein-3 Family Members and Their Biological Functions,” Frontiers in Bioscience, 9:1520-1529(2004).
Hino et al., “Coordination of BMP-3b and cerebus is required for head formation of Xenopus embryos”, Developmental Biology, 260(1): 138-157(2003).
Nagaso et al., “Dual Specificity of Activin Type II Receptor ActRIIb in Dorso-Ventral Patterning During Zebrafish Embryogenesis”, Development Growth and Differentiation, 41(2)119-133(1999).
Neuhaus, H., et al., “Heart specific expression of mouseBMP-10a novel member of the TGF-β superfamily,” Mechanisms of Development, 80:181-184 (1999).
Pashmforoush, M., et al., “Nkx2-5 Pathways and Congential Heart Disease: Loss of Ventricular Myocyte Lineage Specification Leads to Progressive Cardiomyopathy and Complete Heart Block,” Cell, 117:373-386 (2004).
Takao et al., “Identification of Rat Bone Morphogenetic Protein-3b (BMP-3b), a New Member of BMP-3”, Biochemical and Biophysical Research Communications, 219(2)656-662(1996).
Teichmann, U., and Kessel, M., “Highly restricted BMP10 expression in the trabeculating myocardium of the chick embryo,” Dev Genes Evol., 214:96-98 (2004).
Bork, 2000, Powers and pitfalls in sequence analysis: the 70% hurdle, Genome Res. 10:398-400.
Brenner, 1999, Errors in genome annotation, Trends in Genetics, 15(4):132-133.
Doerks et al., 1998, Protein annotation: detective work for function prediction, Trends in Genetics, 14(6):248-250.
Graddis et al., 2002, Designing proteins that work using recombinant technologies, Curr. Pharm. Biotechnol. 3:285.
Ngo et al., 1994, Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Skolnick et al., 2000, From genes to protein structure and function: novel applications of computational approaches in the genomic era, Trends in Biotech. 18(1):34-39.
Smith et al., 1997, The challenges of genome sequence annotation or “the devil is in the details,” Nature Biotech. 15:1222-1223.
Wells. 1990, Additivity of mutational effects in proteins, Biochemistry 29(37):8509-8517.
Srivastava, Nature, Jun. 2004, 429:819-822.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

GDF3 propeptides and related methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GDF3 propeptides and related methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GDF3 propeptides and related methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4021210

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.